A small proof-of-principle trial suggests MDMA-assisted therapy may be feasible and effective for depression, but open-label design and a highly pre-treated sample urge caution.
[read the full story...]
Experts from across clinical trials, psychotherapy and regulation have been reflecting on the big challenges facing the field of psychedelics and mental health, following a late 2024 webinar hosted by IAMHRF. This new commentary explores where psychedelic mental health treatments might be heading and what needs to happen next.
[read the full story...]
Anya Borissova and Philip Brooks consider a recent review exploring MDMA-assisted psychotherapy and psilocybin-assisted psychotherapy for trauma-related mental health difficulties.
[read the full story...]
Anya Borissova reviews a recent UK pilot study which suggests that MDMA-assisted psychotherapy is a feasible intervention to use in people with alcohol use disorder. Now we need randomised trials that can reliably measure safety and effectiveness.
[read the full story...]
Aster Daniel summarises a recent study exploring post-traumatic growth after MDMA-assisted psychotherapy for PTSD (post-traumatic stress disorder).
[read the full story...]
